Summary:
Nizam’s Institute of Medical Sciences and Indian Institute of Science are exploring a long-term collaboration to integrate artificial intelligence into healthcare, aiming to improve diagnosis, treatment, and patient outcomes. Discussions with the TANUH Foundation and IISc’s AI Centre of Excellence focused on deploying AI in areas such as cancer risk assessment, kidney disease, diabetes, and vascular conditions. The partnership may include joint research, development of clinical AI tools, and setting up an AI lab at NIMS, with both institutions highlighting its potential to drive more patient-centric innovation.
Nizam’s Institute of Medical Sciences and Indian Institute of Science are exploring a long-term partnership aimed at integrating artificial intelligence into healthcare to enhance diagnosis, treatment, and patient outcomes.
During a meeting held at NIMS, specialists from the TANUH Foundation and IISc’s AI Centre of Excellence discussed the application of AI tools in real-world clinical environments. Focus areas included breast cancer risk assessment, kidney health, diabetes management, and vascular disease modelling.
The TANUH Foundation proposed collaborative multi-centre research, joint development of clinical AI solutions, and data-driven initiatives in precision medicine, along with support for establishing an AI laboratory at NIMS. Faculty members from both institutions identified key priority areas, describing the proposed collaboration as a move toward more patient-focused innovation.
Related posts:
Google Cloud Unveils Advanced AI Agents to Transform Healthcare
Trump Administration May Tie U.S. Drug Prices to Global Rates, Raising Industry Concerns
Domestic Medical Device Firms Eye Growth Under India-UK FTA, Call for Greater Transparency
Centre Reopens PLI Scheme Applications for 11 Pharma Products to Boost Domestic Manufacturing
Sun Pharma, Lupin, Dr Reddy’s Recall Drugs in US Market
